Table 2.
Characteristics and Prevalence of Most Common PIMs Among Patients Who Were Prescribed at Least One PIM at Discharge (n = 1,576)
| PIM | Medication(s) Flagged in Study Patients | Evidence Source(s) | No. (%) of Patients With Any Prescription at Discharge | No. (%) of Patients With New Prescription at Discharge |
|---|---|---|---|---|
| Benzodiazepines in patients without epilepsy or anxiety | Diazepam, oxazepam, lorazepam, bromazepam, alprazolam, flurazepam, nitrazepam, temazepam | AGS Beers Criteria®, STOPP, Choosing Wisely | 408 (25.9) | 114 (7.2) |
| Proton pump inhibitors in patients without gastrointestinal hemorrhage or peptic ulcer not taking anticoagulant agents | Omeprazole, pantoprazole, lansoprazole, rabeprazole, esomeprazole, dexlansoprazole | AGS Beers Criteria®, STOPP, Choosing Wisely | 131 (8.3) | 64 (4.1) |
| Cyclooxygenase‐2 inhibitors in patients with hypertension | Celecoxib | STOPP | 88 (5.6) | 61 (3.9) |
| Selective α‐1‐adrenergic blocking agents in patients with hypertension without prostatic hypertrophy | Alfuzosin, tamsulosin, silodosin | STOPP, AGS Beers Criteria®, Choosing Wisely | 88 (5.6) | 56 (3.6) |
| Opioids in patients with delirium without cancer | Codeine, fentanyl, hydromorphone, morphine, oxycodone | AGS Beers Criteria®, STOPP, Choosing Wisely | 47 (3.0) | 31 (2.0) |
| Atypical antipsychotics in patients with delirium without schizophrenia or bipolar affective disorder | Aripiprazole, olanzapine, quetiapine, risperidone | AGS Beers Criteria®, STOPP, Choosing Wisely | 42 (2.7) | 32 (2.0) |
Abbreviations: AGS, American Geriatrics Society; PIM, potentially inappropriate medication.